Skip to content

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00768196
Acronym
Preedom
Enrollment
2000
Registered
2008-10-07
Start date
2008-09-30
Completion date
2009-02-28
Last updated
2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

GERD, Korea, typical symptom, quality of life, Naturalistic, epidemiological

Brief summary

The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* GERD patients who have experienced heartburn or acid regurgitation during past 7 days * GERD patients who have already undergone endoscopy before enrolment

Exclusion criteria

* Involvement in the planning and conduct of the programme * The person who took the medicine such as PPI or H2RA during the last 7 days * Severe systemic disease

Design outcomes

Primary

MeasureTime frame
The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.

Secondary

MeasureTime frame
The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026